People who access Onduo through their employer will have access to the wearables and Fitbit’s subscription program. Google closed its acquisition of Fitbit earlier this year, and Onduo is a subsidiary of Google's sister company, Verily.
The companies will launch a randomized, controlled trial to see how access to gum irrigation and a smart toothbrush changes their oral health, blood sugar and artery health.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Verily’s virtual diabetes platform, Onduo, is expanding to support additional conditions and languages, Onduo’s CEO Vindell Washington shared. How will the company differentiate itself among a growing number of multi-condition platforms, such as Livongo and Omada?
Alphabet and other investors poured $700 million in funding into Verily last week. The company, which is Alphabet’s life sciences subsidiary, plans to pour some of the funds into supporting Covid-19 vaccine studies and programs for businesses.
Alphabet’s “moonshot” subsidiary X shared that it failed to find a single biomarker for depression and anxiety. But the company still plans to make its research, which included developing portable EEGs, available to the public.
Google’s sister company launched a program in California and other states to help route patients to nearby coronavirus testing. Dr. Vivian Lee, president of health platforms for Verily, shared lessons learned from that effort and Verily’s work with schools and businesses.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Alphabet’s healthcare subsidiary, Verily, will partner with Swiss Re Corporate Solutions to create a new stop-loss insurance company. The new entity, called Coefficient, will use data analytics to help self-funded companies manage unexpected areas of cost.
CityBlock Health, a company building out healthcare services for low-income communities, raised $53.5 million in a series B extension. The company plans to use the funds to expand its clinical programs and further develop its technology.
Oscar Health raised $225 million in funding from new and existing investors. The insurance startup is currently operating in 29 markets.
Verily, Alphabet’s life sciences arm, is launching a new study to better understand the immune response to Covid-19 and gain more information on the accuracy of tests.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Fitbit saw its margins decline from last year, after it rolled out a series of lower-priced devices to woo new users. The company is on the verge of being acquired by Google for $2.1 billion, with the deal pending regulators’ approval.
After Miki Kapoor joined Verana Health in 2018, the company shifted from a tele-ophthalmology startup to a data analytics company. Since then, Verana has raised $100 million in funding led by GV and made its first major acquisition.
The partnership adds to Verily’s growing work in value-based reimbursement.
Color vice president for research and scientific affairs Alicia Zhou explained that there is an ethical obligation to provide information on actionable genes, but costs and logistics have previously made doing so prohibitive.
The company just announced strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to develop new clinical research programs utilizing the Project Baseline platform across therapeutic areas ranging from cardiovascular disease to oncology to mental health.